Thus, the expanding type 2 diabetes market is driving the demand for GLP-1 drugs
5 Obesity is the main risk factor for obstructive sleep apnea, raising the possibility that weight loss may reduce incidence of this disorder, along with the need for continuous positive airway pressure (CPAP) devices
Neither study showed a significant increase in amylase (7% for both studies) or lipase (28% in the LEADER trial and 31% in the SCALE trial) values after starting liraglutide compared with placebo, and the positive predictive values of amylase and lipase for pancreatitis were less than 1%
A large number of the aging population is mainly affected by it
However, it is reasonable to anticipate storage requirements similar to other injectable incretin-based medicines such as Mounjaro and Wegovy
Lipovia positions itself as activating your bodys natural GLP-1, not replacing it with a drug